1-hexadecyl-2-acetyl-glycero-3-phosphocholine and triazolam

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with triazolam in 20 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (triazolam)	Trials (triazolam)	Recent Studies (post-2010) (triazolam)
9,156	187	552	1,275	385	90

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (40.00)	18.7374
1990's	11 (55.00)	18.2507
2000's	1 (5.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jonas, JM	1
Blank, B; Kempe, ER	1
Adam, K; Oswald, I	2
Casals-Stenzel, J	2
Gustow, E; Pieringer, RA; Ved, HS	1
Abendschein, DR; Bergmann, SR; Haskel, EJ; Torr, SR; VonVoigtlander, PF	1
Ferracin, F; Gurari-Rotman, D; Pletscher, A	1
Cavero, I; Durand, G; Floch, A; James, C; Lave, D; Le Fur, G; Mondot, S; Pacot, D; Robaut, C; Sedivy, P	1
Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM	1
Casals-Stenzel, J; Weber, KH	1
Cagen, LM; Chesney, CM; Pifer, DD	1
Cox, CP; Wood, KL	1
Ehrlich, YH; Kornecki, E; Lenox, RH	1
Feuerstein, G; Friedman, E; Wang, HY; Yue, TL	1
Jørgensen, L; Kinlough-Rathbone, RL; Mustard, JF; Nilsen, GJ; Perry, DW	1
Gardner, CR; Laskin, DL; Laskin, JD	1
Kishore, K; Saraf, MK; Sharma, A; Singh, M; Thomas, KM	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and triazolam

Article	Year
Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status. Lipids, 1991, Volume: 26, Issue:12 Topics: Animals; Azepines; Central Nervous System; Flumazenil; Humans; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Triazolam; Triazoles	1991

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and triazolam

Article	Year
Triazolam and PAF. Lancet (London, England), 1991, Dec-07, Volume: 338, Issue:8780 Topics: Dose-Response Relationship, Drug; Humans; Intradermal Tests; Male; Platelet Activating Factor; Time Factors; Triazolam	1991

Other Studies

18 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and triazolam

Article	Year
Triazolam and PAF inhibition. Lancet (London, England), 1992, Jan-04, Volume: 339, Issue:8784 Topics: Brain; Humans; Platelet Activating Factor; Triazolam	1992
Triazolam and PAF inhibition. Lancet (London, England), 1992, Jan-04, Volume: 339, Issue:8784 Topics: Azepines; Clinical Trials as Topic; Drug Administration Schedule; Humans; Platelet Activating Factor; Triazolam; Triazoles	1992
[Triazolam is different: it is a PAF antagonist]. Der Anaesthesist, 1992, Volume: 41, Issue:2 Topics: Benzodiazepines; Humans; Platelet Activating Factor; Triazolam	1992
Possible mechanism for adverse reactions to triazolam. Lancet (London, England), 1991, Nov-02, Volume: 338, Issue:8775 Topics: Alprazolam; Anxiety; Humans; Platelet Activating Factor; Receptors, GABA-A; Substance Withdrawal Syndrome; Triazolam	1991
Regulation of neuronal differentiation in neuron-enriched primary cultures from embryonic rat cerebra by platelet activating factor and the structurally related glycerol ether lipid, dodecylglycerol. Journal of neuroscience research, 1991, Volume: 30, Issue:2 Topics: Acetylcholinesterase; Animals; Brain; Cell Differentiation; Cells, Cultured; Choline O-Acetyltransferase; Cytoplasm; Female; Glycerides; L-Lactate Dehydrogenase; Laurates; Monoglycerides; Neurons; Platelet Activating Factor; Pregnancy; Rats; Triazolam	1991
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor. Journal of the American College of Cardiology, 1991, Volume: 18, Issue:7 Topics: Administration, Oral; Animals; Benzodiazepines; Bleeding Time; Blood Coagulation; Blood Flow Velocity; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Hemodynamics; Partial Thromboplastin Time; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Recurrence; Tissue Plasminogen Activator; Triazolam; Triazoles	1991
LDL induced shape change reaction of platelets is not due to PAF. Thrombosis research, 1989, Nov-15, Volume: 56, Issue:4 Topics: Azepines; Blood Platelets; Glyceryl Ethers; Humans; In Vitro Techniques; Lipoproteins, LDL; Platelet Activating Factor; Thiazoles; Thienopyridines; Triazolam	1989
PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. Biochemical pharmacology, 1987, Oct-01, Volume: 36, Issue:19 Topics: Animals; Blood Platelets; Diterpenes; Furans; Ginkgolides; In Vitro Techniques; Kinetics; Lactones; Male; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pyridines; Rabbits; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Stereoisomerism; Thiazoles; Triazolam; Tritium	1987
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. Biochemical pharmacology, 1988, Aug-01, Volume: 37, Issue:15 Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction	1988
Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. British journal of pharmacology, 1987, Volume: 90, Issue:1 Topics: Animals; Anti-Anxiety Agents; Azepines; Benzodiazepinones; Central Nervous System; Flumazenil; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Receptors, GABA-A; Tidal Volume; Triazolam	1987
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. Biochemical and biophysical research communications, 1987, Apr-14, Volume: 144, Issue:1 Topics: Alprazolam; Binding, Competitive; Blood Platelets; Diazepam; Humans; In Vitro Techniques; Kinetics; Platelet Activating Factor; Platelet Aggregation; Triazolam	1987
Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo. Naunyn-Schmiedeberg's archives of pharmacology, 1987, Volume: 335, Issue:3 Topics: Alprazolam; Animals; Azepines; Blood Pressure; Guinea Pigs; Humans; Hypnotics and Sedatives; In Vitro Techniques; Injections, Intravenous; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Respiration; Triazolam	1987
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. Thrombosis research, 1987, Aug-01, Volume: 47, Issue:3 Topics: Alprazolam; Animals; Blood Platelets; Furans; In Vitro Techniques; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thiazoles; Triazolam	1987
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science (New York, N.Y.), 1984, Dec-21, Volume: 226, Issue:4681 Topics: Adenosine Diphosphate; Alprazolam; Anti-Anxiety Agents; Arachidonic Acid; Arachidonic Acids; Benzodiazepines; Blood Platelets; Calcimycin; Chromatography, Gel; Collagen; Epinephrine; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin; Triazolam	1984
Platelet-activating factor: diminished acetylcholine release from rat brain slices is mediated by a Gi protein. Journal of neurochemistry, 1994, Volume: 63, Issue:5 Topics: Acetylcholine; Alprazolam; Animals; Brain; Cerebral Cortex; GTP-Binding Proteins; Hippocampus; Norepinephrine; Platelet Activating Factor; Potassium; Rats; Serotonin; Tetrodotoxin; Triazolam; Tritium	1994
Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:7 Topics: Adenosine Diphosphate; Alprostadil; Animals; Cell Communication; Cells, Cultured; Centrifugation, Density Gradient; Creatine Kinase; Edetic Acid; Ferric Compounds; Macrophages, Alveolar; Microscopy, Electron; Phosphocreatine; Platelet Activating Factor; Platelet Activation; Rabbits; Thrombin; Triazolam	1993
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells. Journal of leukocyte biology, 1993, Volume: 53, Issue:2 Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil	1993
Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. Behavioural brain research, 2003, Jun-16, Volume: 142, Issue:1-2 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Amnesia, Anterograde; Amnesia, Retrograde; Animals; Anti-Anxiety Agents; Azepines; Diazepam; Diterpenes; Escape Reaction; Female; Flumazenil; Ginkgolides; Lactones; Learning; Male; Mice; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Reaction Time; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, GABA-A; Retention, Psychology; Triazolam	2003